NANO · Nanobiotix SA
24.06
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro1.22B
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 21/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Big Candle
- Big Candle (Realtime)
- HALO 100
- HALO 200
- HALO All
- HALO Balance Sheet
- HALO Capital Efficiency
Key Fundamentals
EPS 3 yr Growth
-69.40%
EBITDA Margin
-41.20%
Operating Cashflow
-€35m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-1.20
Quick Ratio
1.10
Performance
52 weeks range
Low 13.1 - 47.66
Trade Value (12mth)
US$1,685,202.00
1 week
23.01%
1 month
-20.44%
YTD
26.63%
1 year
55.43%
All time high
47.66
Additional Data
Shares Outstanding (Fully Diluted)
49m
HALO Sector
Healthcare
Next Company Report Date
27-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Weak
Growth
Earnings
Neutral
Dividends
Very Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Invus Financial Advisors LLC | Private Company |
| Laurent Lévy | Individual |
| Bart van Rhijn | Individual |
| Anne-Juliette Hermant | Individual |
| Gary M. Phillips | Individual |
